Related Experiment Video
Updated: Aug 9, 2026

07:34
FISH for Pre-implantation Genetic Diagnosis
Published on: February 24, 2011
Split-signal FISH for detection of chromosome aberrations
J J M van Dongen1, M van der Burg, A W Langerak
1Department of Immunology, Erasmus MC, Rotterdam, The Netherlands. j.j.m.vandongen@erasmusmc.nl
Hematology (Amsterdam, Netherlands)
|September 29, 2005
Summary
This study introduces a rapid and sensitive split-signal fluorescence in situ hybridization (FISH) assay for detecting chromosome aberrations in blood cancers. This method improves accuracy and aids in classifying malignancies and defining patient risk groups.
Area of Science:
- Molecular Biology
- Cytogenetics
- Oncology
Background:
- Chromosome aberrations are common in hematopoietic malignancies, leading to oncogene dysregulation or fusion proteins.
- Accurate detection of these aberrations is crucial for cancer classification and determining appropriate treatment strategies.
- Existing methods like fusion-signal FISH have limitations in detecting all types of aberrations.
Purpose of the Study:
- To develop rapid and sensitive split-signal fluorescence in situ hybridization (FISH) assays for detecting common chromosome aberrations.
- To overcome limitations of classical FISH methods in identifying chromosomal abnormalities in hematologic cancers.
Main Methods:
- Development of split-signal FISH assays utilizing two differentially labeled probes within a single gene, flanking the breakpoint region.
- Analysis of signal patterns: co-localized signals in normal karyotypes versus split signals indicating a translocation.
- Comparison with classical fusion-signal FISH approaches.
Main Results:
- The split-signal FISH assay demonstrated high sensitivity and rapidity in detecting chromosome aberrations.
- This method offers independence from the specific partner gene involved in the aberration.
- Reduced false-positivity rates compared to traditional FISH techniques.
Conclusions:
- Split-signal FISH is a powerful and versatile tool for identifying chromosome aberrations in hematopoietic malignancies.
- The assay facilitates accurate cancer classification and risk stratification, guiding personalized treatment protocols.
- This technique enhances diagnostic precision and efficiency in hematologic oncology.

